Ciena reported standout fiscal Q4 2025 results with revenue of $1.35 billion (up 20% y/y, 11% q/q), a 43.4% gross margin and adjusted EPS of $0.91, while full-year revenue came in at $4.77 billion, orders at $7.8 billion and backlog roughly $5 billion versus $2.1 billion a year earlier. Management guided fiscal 2026 revenue growth to 20%–28%, Q1 revenue to about $1.39 billion (~30% y/y), raised the operating-margin target to 17% and flagged a near-term Q2 margin dip from higher 800ZR mix with improvement expected in H2; Rosenblatt’s Mike Genovese kept a Buy, lifted the price target to $305 and sharply raised FY26–27 EPS estimates, citing Ciena’s leadership in the scale-across and 800ZR opportunity. Despite the upbeat results and upgraded forecasts, shares fell about 10.3% to $217.39 at publication, reflecting short-term market skepticism despite clearer backlog-driven visibility and momentum into 2026.
Ciena reported a standout fiscal Q4 2025 with revenue of $1.35 billion (up 20% year-over-year and 11% sequentially), beating estimates by roughly $70 million; gross margin expanded to 43.4% (up 150 bps q/q and 80 bps above the firm model) and adjusted EPS was $0.91 versus a $0.74 estimate. For the full year the company posted $4.77 billion in revenue, $7.8 billion in orders and exited with approximately $5.0 billion of backlog versus $2.1 billion a year earlier, providing visible demand traction. Management guided Q1 FY26 revenue to about $1.39 billion (roughly 30% y/y and ~$140 million above consensus) and lifted fiscal 2026 revenue growth guidance to 20%–28% while raising an operating-margin target to 17% from 16%; Rosenblatt’s Mike Genovese maintained a Buy, increased the price target to $305 and materially raised FY26 EPS to $5.25 (FY27 EPS $6.78). The analyst highlighted Ciena’s leadership in the scale-across opportunity and 800ZR pluggable market, estimating near-full share of line systems for scale-across and dozens of multi‑$10M to $100M projects in FY26. Shares fell about 10.3% to $217.39 despite the beat and bullish analyst revisions, reflecting short-term skepticism likely tied to guidance of a Q2 margin dip from increased 800ZR mix and possible profit-taking. Primary near-term risks to monitor are Q2 margin realization, 800ZR pricing/volume dynamics and the pace of backlog conversion; upside depends on H2 margin recovery and the scale-across adoption scenarios Genovese outlined.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment
